Le GLP-1 joue un rle cl dans la rgulation de la glycmie chez les personnes atteintes de diabte de type 2
MAMs are essential for the regulation of the neuronal Ca 2+ concentration via the SERCA, the ER channels inositol 1,4,5-trisphosphate receptors, the glucose-regulated protein 75, the MCU, and the voltage-dependent anion channel (VDAC) [61]
Commonly reported side effects include nausea, vomiting, reduced appetite, constipation, diarrhoea, abdominal discomfort, mild injection-site reactions, and fatigue
In trials, patients lost an average of 15% of their body weight over 68 weeks
When patients do stop taking semaglutide for menopause weight gain, their Midi clinician can help them determine the best next steps